7-81950402-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000722.4(CACNA2D1):c.3266G>T(p.Arg1089Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,612,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000722.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA2D1 | NM_000722.4 | c.3266G>T | p.Arg1089Leu | missense_variant | 39/39 | ENST00000356860.8 | NP_000713.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.3266G>T | p.Arg1089Leu | missense_variant | 39/39 | 1 | NM_000722.4 | ENSP00000349320.3 | ||
CACNA2D1 | ENST00000443883.2 | c.3302G>T | p.Arg1101Leu | missense_variant | 39/39 | 5 | ENSP00000409374.2 | |||
CACNA2D1 | ENST00000705962.1 | c.3146G>T | p.Arg1049Leu | missense_variant | 38/38 | ENSP00000516190.1 | ||||
CACNA2D1 | ENST00000705961.1 | c.3032G>T | p.Arg1011Leu | missense_variant | 37/37 | ENSP00000516189.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151762Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250926Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135598
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461168Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 726890
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151762Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74074
ClinVar
Submissions by phenotype
Brugada syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 03, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with CACNA2D1-related conditions. This variant is present in population databases (rs143631985, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 1089 of the CACNA2D1 protein (p.Arg1089Leu). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2023 | The p.R1089L variant (also known as c.3266G>T), located in coding exon 39 of the CACNA2D1 gene, results from a G to T substitution at nucleotide position 3266. The arginine at codon 1089 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at